Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex

Kirk Jensen (Inventor)

Research output: Patent

Abstract

Described herein are methods for identifying and preparing nucleic acid ligands to tissues. Tissues are de- scribed herein as a collection of macromolecules in a heterogeneous environment. According to this definition, tissues encompass a single cell type, a collection of cell types, an aggregate of cells or an aggregate of macromolecules. The method utilized herein for identifying such nucleic acid ligands is called SELEX, an acronym for Systematic Evolution of Ligands by Exponential enrichment. Specifically disclosed herein are high-affinity nucleic acid ligands which bind to various tissues.
LanguageEnglish
Patent numberEP 0823914 B1
IPCEP 0823914 B1
Publication statusPublished - 25 Aug 2004

Cite this

Jensen, K. (2004). IPC No. EP 0823914 B1. Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex. (Patent No. EP 0823914 B1). European Patent Office.
Jensen, Kirk (Inventor). / Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex. European Patent Office. IPC No.: EP 0823914 B1. Patent No.: EP 0823914 B1.
@misc{0f6b5130db72410ba83b75a3f6bcddb1,
title = "Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex",
abstract = "Described herein are methods for identifying and preparing nucleic acid ligands to tissues. Tissues are de- scribed herein as a collection of macromolecules in a heterogeneous environment. According to this definition, tissues encompass a single cell type, a collection of cell types, an aggregate of cells or an aggregate of macromolecules. The method utilized herein for identifying such nucleic acid ligands is called SELEX, an acronym for Systematic Evolution of Ligands by Exponential enrichment. Specifically disclosed herein are high-affinity nucleic acid ligands which bind to various tissues.",
author = "Kirk Jensen",
year = "2004",
month = "8",
day = "25",
language = "English",
publisher = "European Patent Office",
type = "Patent",
note = "EP 0823914 B1; EP 0823914 B1",

}

Jensen, K 2004, Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex, Patent No. EP 0823914 B1, IPC No. EP 0823914 B1.

Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex. / Jensen, Kirk (Inventor).

European Patent Office. IPC No.: EP 0823914 B1. Patent No.: EP 0823914 B1.

Research output: Patent

TY - PAT

T1 - Systematic Evolution Of Ligands By Exponential Enrichment: Tissue Selex

AU - Jensen, Kirk

PY - 2004/8/25

Y1 - 2004/8/25

N2 - Described herein are methods for identifying and preparing nucleic acid ligands to tissues. Tissues are de- scribed herein as a collection of macromolecules in a heterogeneous environment. According to this definition, tissues encompass a single cell type, a collection of cell types, an aggregate of cells or an aggregate of macromolecules. The method utilized herein for identifying such nucleic acid ligands is called SELEX, an acronym for Systematic Evolution of Ligands by Exponential enrichment. Specifically disclosed herein are high-affinity nucleic acid ligands which bind to various tissues.

AB - Described herein are methods for identifying and preparing nucleic acid ligands to tissues. Tissues are de- scribed herein as a collection of macromolecules in a heterogeneous environment. According to this definition, tissues encompass a single cell type, a collection of cell types, an aggregate of cells or an aggregate of macromolecules. The method utilized herein for identifying such nucleic acid ligands is called SELEX, an acronym for Systematic Evolution of Ligands by Exponential enrichment. Specifically disclosed herein are high-affinity nucleic acid ligands which bind to various tissues.

M3 - Patent

M1 - EP 0823914 B1

PB - European Patent Office

ER -